Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1960.21 Million | USD 3200.94 Million | 5.6% | 2023 |
According to the report published by Zion Market Research, the global Respiratory Pathogen Testing Kits Market size was valued at USD 1960.21 Million in 2023 and is predicted to reach USD 3200.94 Million by the end of 2032. The market is expected to grow with a CAGR of 5.6% during the forecast period. The report analyzes the global Respiratory Pathogen Testing Kits Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Respiratory Pathogen Testing Kits industry.
The potentially life-threatening and serious pneumopathies mainly occur in weakened or immunocompromised individuals such as those in intensive care units, or with cancer & chronic diseases, and in young children. Most respiratory diseases are caused by viruses & bacteria, and as symptomologies are similar, to identify the infectious agents, precise diagnostic testing is important. In such cases, respiratory pathogen testing kits play a crucial role in the detection of respiratory pathogens that cause respiratory illness.
The global respiratory pathogen testing kits market is growing at a significant rate. Factors such as the increase in the prevalence of respiratory disease, the growing necessity of appropriate diagnosis to ensure optimal patient management, and growing initiatives to spread awareness of respiratory illness are driving the growth of the global market. Additionally, the outbreak of the Covid-19 pandemic is one of the major factors that are boosting the global market. Also, respiratory diseases put a tremendous worldwide health burden. It is the third leading cause of death across the world as every year nearly 65 million people suffer from COPD of which around 3 million dies.
Further, around 1.6 million people die with tuberculosis, a most lethal infectious disease, while millions of people including the young & old ones die each year. To reduce such a huge burden of disease there is a need for optimized detection of infectious disease which has led to a rise in funding for the research on respiratory diagnostics. All these factors are fueling the growth of the global respiratory pathogen testing kits market. In addition to this, growing research on molecular diagnosis and PCR technologies is also fostering the growth of the global market. Moreover, factors such as a rise in the number of respiratory pathogens testing in clinical labs and a rise in investments for the development of the kits are augmenting the growth of the global market.
Furthermore, the rise in online testing platforms will provide numerous opportunities for the growth of the global respiratory pathogen testing kits market during the forecast period. However, the lack of expertise required for sample collection and processing may hamper the growth of the global respiratory pathogen testing kits market.
Current Covid-19 pandemic conditions have forced market players to fulfill the outraging demand for respiratory pathogen testing kits. Also, due to the nature of the Covid-19 infection, the demand for respiratory pathogen testing kits is witnessing high demand. Also, the government's supports to boost the manufacturing of the diagnostic kits to meet the global demand have positively affected the growth of the market in 2020. The market is expected to witness high growth over the forecast period due to ongoing pandemic conditions.
The global respiratory pathogen testing kits market is classified into technology, symptoms/infection, product, end-user, and region.
Based on the technology, the global respiratory pathogen testing kits market is bifurcated into immunoassay, NAAT (Nucleic Acid Amplification), and others.
Based on symptoms/infection, the global market is divided into pneumonia, respiratory syncytial virus infection, rhinovirus infection, influenza virus infection, human coronavirus infection, enterovirus infection, by matrix, and others.
The product segment consists of ELISA kits, DFA kits, RT PCR kits, and others.
Specialty clinics, diagnostic centers, and hospitals are the end-users of the global market.
Report Attributes | Report Details |
---|---|
Report Name | Respiratory Pathogen Testing Kits Market |
Market Size in 2023 | USD 1960.21 Million |
Market Forecast in 2032 | USD 3200.94 Million |
Growth Rate | CAGR of 5.6% |
Number of Pages | 205 |
Key Companies Covered | Hoffmann-La Roche Ltd., Altona Diagnostics, MyLab, Thermo Fisher Scientific Corporation, Abbot Laboratories, Becton Dickinson and Company, Danaher Corporation, bioMerieux Inc., Veredus Laboratories Pte Ltd, and Seegene Inc |
Segments Covered | By technology, By symptoms, By product, By end-user and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Asia Pacific is estimated to lead the global respiratory pathogen testing kits market during the forecast period. The growing cases of Covid-19 in India and strict regulations put forth by the government to perform the test while traveling within the district region is the prime factor contributing to the growth of the market in this region. In addition to this, growing healthcare expenditure and growing demand for appropriate diagnosis of respiratory disease are also some of the prime factors that are spurring the growth of the market in this region. North America and Europe are also expected to account for the significant share of the market due to an increase in R&D in respiratory diagnosis and the development of innovative products.
are some of the major players that are operating in the global respiratory pathogen testing kits market.
The Global Respiratory Pathogen Testing Kits Market is segmented as follows:
By technology
By symptoms/infection
By product
By end-user
FrequentlyAsked Questions
Factors such as the increase in the prevalence of respiratory disease, the growing necessity of appropriate diagnosis to ensure optimal patient management, and growing initiatives to spread awareness of respiratory illness are driving the growth of the global market. Furthermore, the rise in online testing platforms will provide numerous opportunities for the growth of the global respiratory pathogen testing kits market during the forecast period.
Hoffmann-La Roche Ltd., Altona Diagnostics, MyLab, Thermo Fisher Scientific Corporation, Abbot Laboratories, Becton Dickinson and Company, Danaher Corporation, bioMerieux Inc., Veredus Laboratories Pte Ltd, and Seegene Inc are some of the major players that are operating in the global respiratory pathogen testing kits market.
Asia Pacific is estimated to lead the global respiratory pathogen testing kits market during the forecast period. The growing cases of covid-19 in India and strict regulations put forth by the government to perform the test while traveling within the district region is the prime factor contributing to the growth of the market in this region. In addition to this, growing healthcare expenditure and growing demand for appropriate diagnosis of respiratory disease are also some of the prime factors that are spurring the growth of the market in this region.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed